Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of the Touro College & University System, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to Scholarly Communications Librarian Carrie Levinson.

Total number of publications: 7,320

Enter a faculty name:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

First Prev 1 2 3 4 5 6 7 8 9 10 Next Last
  • Abou-Karam, N., Bradford, C. D., Lor, K. B., Barnett, M. J., Ha, M., & Rizos, A. (2016). Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease. SAGE Open Medicine, 4 [Article 2050312116632426]. doi:10.1177/2050312116632426

  • Absher, R. K., Gerkin, T. M., & Banares, L. W. (2010). Alvimopan use in laparoscopic and open bowel resections: Clinical results in a large community hospital system. Annals of Pharmacotherapy, 44(11), 1701-1708. doi:10.1345/alph.1P260

  • Addo-Atuah, J. (2011). Performance and perceptions of pharmacy students using team-based learning (TBL) within a global health course. Innovations in Pharmacy, 2(2) [Article 37]. This material can be found here.

  • Addo-Atuah, J. (2014). Making a case for a public health orientation in global pharmacy education and practice in the context of the Millennium Development Goals (MDGs). Currents in Pharmacy Teaching and Learning, 6(5), 723-729. doi:10.1016/j.cptl.2014.05.019

  • Addo-Atuah, J. (2016). Access to medicines (Developing world). In S. Boslaugh (Ed.), SAGE encyclopedia of pharmacology and society (pp. 14-21). Thousand Oaks, CA: SAGE.

  • Addo-Atuah, J. (2016). Access to medicines (Industrialized world). In S. Boslaugh (Ed.), SAGE encyclopedia of pharmacology and society (pp. 21-26). Thousand Oaks, CA: SAGE.

  • Addo-Atuah, J. (2016). Medicare: Prescription drug benefits. In S. Boslaugh (Ed.), SAGE encyclopedia of pharmacology and society (pp. 886-890). Thousand Oaks, CA: SAGE.

  • Addo-Atuah, J. (2016). My personal musings about pharmacy education and practice in Ghana. Regulator, 4(4), 8-9.

  • Addo-Atuah, J. (2016). Patient Protection and Affordable Care Act (Obamacare). In S. Boslaugh (Ed.), SAGE encyclopedia of pharmacology and society (pp. 1037-1044). Thousand Oaks, CA: SAGE.

  • Addo-Atuah, J. (2016). Pharmacoeconomics. In S. Boslaugh (Ed.), SAGE encyclopedia of pharmacology and society (pp. 1089-1096). Thousand Oaks, CA: SAGE.

  • Addo-Atuah, J. (2016). TRIPS Agreement (The Trade-Related Aspects of Intellectual Property Rights), Doha Declaration, TRIPS Plus. In S. Boslaugh (Ed.), SAGE encyclopedia of pharmacology and society (pp. 1440-1443). Thousand Oaks, CA: SAGE.

  • Addo-Atuah, J., & Lundmark, W. (2015). [Review of the book Introduction to health research methods: A practical guide, by K. H. Jacobsen]. Currents in Pharmacy Teaching & Learning, 7(3), 424-425. doi:10.1016/j.cptl.2014.12.001

  • Addo-Atuah, J., Dutta, A., & Kovera, C. (2014). A global health elective course in a PharmD curriculum. American Journal of Pharmaceutical Education, 78(10) [Article 187]. doi:10.5688/ajpe7810187

  • Addo-Atuah, J., Gourley, D., Gourley, G., White-Means, S. I., Womeodu, R. J., Faris, R. J., & Addo, N. A. (2012). Accessibility of antiretroviral therapy in Ghana: Convenience of access. Sahara Journal, 9(2), 74-87. doi:10.1080/17290376.2012.683581

  • Akhtar, A., Befkadu, E., Basu, P., & Kumar, P. (2014). Exposing the origins of the Ebola outbreak: Urging for a shift in response from reactive to proactive. American Journal of Infectious Diseases and Microbiology, 2(6A), 1-18. This material can be found here.

  • Allen, W. J., Yi, H. A., Gochin, M., Jacobs, A., & Rizzo, R. C. (2015). Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation. Bioorganic & Medicinal Chemistry Letters, 25(14), 2853-2859. doi:10.1016/j.bmcl.2015.04.067

  • Anreddy, N., Patel, A., Zhang, Y. K.,  Wang, Y. J., Shukla, S., Kathawala, R. J., . . . Kumar, P. (2015). A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo. Cancer Research, 75(Suppl. 15) [Article 4432]. doi:10.1158/1538-7445.AM2015-4432

  • Anreddy, N., Patel, A., Zhang, Y. K., Wang, Y. J., Shukla, S., Kathawala, R. J., . . . Kumar, P. (2015). A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo. Oncotarget, 6(36), 39276-39291. doi:10.18632/oncotarget.5747

  • Arnaboldi, P. M., Sambir, M., D'Arco, C., Peters, L. A., Seegers, J. F., Mayer, L., McCormick, A. A., & Dattwyler, R. J. (2016). Intranasal delivery of a protein subunit vaccine using a tobacco mosaic virus platform protects against pneumonic plague. Vaccine, 34(47), 5768-5776. doi:10.1016/j.vaccine.2016.09.063

  • Aronson, Y., & Addo-Atuah, J. (2013). Accessibility of essential medicines in New York City by zip code income levels and boroughs. Innovations in Pharmacy, 4(3) [Article 127].  This material can be found here.

  • Aruoma, O. I. (2010). Functional nutraceuticals. Toxicology, 278(1), 2-5. doi:10.1016/j.tox.2010.09.009

  • Aruoma, O. I., & Bahorun, T. (2010). The future of biomarkers. Toxicology, 278(2), 161-164. doi:10.1016/j.tox.2010.09.015

  • Askari, B., Wietecha, T., Hudkins, K. L., Fox, E. J., O'Brien, K. D., Kim, J., . . . Alpers, C. E. (2014). Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse. Laboratory Investigation, 94, 851–862. doi:10.1038/labinvest.2014.80

  • Assefa, H. (2014). Ebola virus potential drug targets and prospects for small molecule drug discovery. Journal of Pharmaceutical Sciences and Pharmacology, 1(4), 313-321. doi:10.1166/jpsp.2014.1031

  • Atmar, R. L., Greenberg, S. B., Quarles, J. M., Wilson, S. Z., Tyler, B., Feldman, S., & Couch, R. B. (1990). Safety and pharmacokinetics of rimantadine small-particle aerosol. Antimicrobial Agents and Chemotherapy, 34(11), 2228-2233.

First Prev 1 2 3 4 5 6 7 8 9 10 Next Last